Corneal Ulcer Clinical Trial
— CUPOfficial title:
Corneal Ulcer Prevention Through Health Education
A community-randomized trial comparing villages randomized to receive an intervention consisting of a trained community health volunteer who brings patients to the nearest Vision Centers or Primary Health Care Centers for treatment after diagnosing a corneal abrasion to control villages receiving no additional intervention. The primary outcome of corneal ulcer will be measured by baseline and annual population-based census performed in both intervention and control villages by masked examiners from baseline to 24 months. Each resident in the village will be asked about their ocular history and, if suspected of having a corneal ulcer, will be examined for evidence of a corneal opacity. Annual visits will occur, coinciding with the end of the harvest season. In villages randomized to intervention, an active promotion campaign will be undertaken to urge residents to notify the village eye health worker within 24 hours of ocular trauma. In control villages, abrasions and ulcers will be treated if they present to a clinic or are found during the annual monitoring visits, but active promotion of corneal abrasion care will not be offered.
Status | Not yet recruiting |
Enrollment | 98207 |
Est. completion date | December 2017 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Presence of a corneal abrasion - Willingness to be treated with topical antibiotic and antifungal ointments 3 times a day for 3 days - Appropriate consent Exclusion Criteria: - Evidence of a corneal ulcer - Evidence of other acute eye disease requiring urgent care - Known allergy to study medications - Not willing to participate |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Aravind Eye Care System | Proctor Foundation |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Corneal Ulcer | The primary outcome for the trial will be the incidence of corneal ulceration in the two study arms as measured by field examination. | 2 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05705024 -
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
|
Phase 2 | |
Completed |
NCT02731638 -
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
|
Phase 3 | |
Completed |
NCT00324168 -
Steroids for Corneal Ulcers Trial
|
Phase 4 | |
Completed |
NCT04484402 -
Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells
|
Phase 1/Phase 2 | |
Completed |
NCT04820010 -
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
|
||
Recruiting |
NCT02570321 -
Cross-linking for Corneal Ulcers Treatment Trial
|
Phase 4 | |
Completed |
NCT00386958 -
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
|
Phase 2 | |
Completed |
NCT04054817 -
ACRO Biocornea Clinical Trial in Taiwan
|
N/A | |
Completed |
NCT00997035 -
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
|
Phase 3 | |
Completed |
NCT02277054 -
Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty
|
N/A | |
Recruiting |
NCT05313828 -
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
|
||
Recruiting |
NCT05255107 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
|
Phase 2/Phase 3 | |
Recruiting |
NCT05255016 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
|
Phase 2/Phase 3 | |
Completed |
NCT05891106 -
AONDA Therapeutic Indication Study I
|
||
Terminated |
NCT00789646 -
Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients
|
N/A | |
Not yet recruiting |
NCT05940376 -
Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
|
||
Completed |
NCT05200000 -
Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis
|
Phase 1 | |
Completed |
NCT01756456 -
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01969786 -
Village Integrated Eye Workers Trial
|
N/A | |
Completed |
NCT01794312 -
Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
|
Phase 3 |